ISG15-modification of the Arp2/3 complex restricts pathogen spread

Yifeng Zhang, Brittany M. Ripley, Wei Ouyang, Miranda Sturtz, Ellen M. Upton, Emma K. Luhmann, Madeleine Vessely, Rocío Coloma, Nathan Schwery, Scott M. Anthony, Adam Goeken, Thomas O. Moninger, John T. Harty, Aloysius J. Klingelhutz, Emma Lundberg, David K. Meyerholz, Balaji Manicassamy, Christopher S. Stipp, Susana Guerra, Lilliana RadoshevichbioRxiv 2022 · DOI

In the high-stakes arms race between host cells and pathogens, the cytoskeleton is the battlefield. Many pathogens, such as Listeria monocytogenes and Vaccinia virus, hijack the host’s actin-polymerization machinery—specifically the Arp2/3 complex—to propel themselves through the cytoplasm and leap into neighboring cells.

A recent paper published in bioRxiv by Zhang et al. reveals a fascinating new layer of defense: the immune system can "clog" this cellular engine using a small protein called ISG15. However, as with many immune responses, too much of a good thing can backfire.

TL;DR

Researchers discovered that the interferon-stimulated protein ISG15 covalently modifies the Arp2/3 complex (a process called ISGylation), physically slowing down actin filament formation. While this normally restricts the spread of viruses and bacteria, Listeria can exploit dysregulated ISGylation to form multi-headed "bazookas" that drive deeper into host tissues, increasing mortality.

What Problem Does This Paper Address?

When a cell detects an infection, it releases interferons, which trigger the expression of hundreds of "Interferon-Stimulated Genes" (ISGs). One of the most prominent is ISG15, a ubiquitin-like protein that can be tagged onto other proteins to change their function.

While we’ve known for years that ISG15 is critical for antiviral and antibacterial defense, we didn't know exactly how it affected its targets. This paper identifies the Arp2/3 complex—the "engine" that builds the actin skeleton—as a primary target. The authors sought to understand how ISGylation of this complex changes its behavior and how pathogens react to it.

Methods

The team employed a multi-disciplinary approach to bridge the gap between molecular biochemistry and whole-organism pathology:

  • Proteomics: They cross-referenced the "ISGylome" (all proteins modified by ISG15) with the known proteome of Listeria actin tails to identify Arp2/3 as a target.
  • CRISPR/Cas9: Used to create "knockout" (KO) cells lacking ISG15 and "catalytically inactive" (CA) mutant mice that cannot remove ISG15 from proteins, leading to hyper-ISGylation.
  • Super-Resolution Microscopy (STED): To visualize the fine structure of actin "comet tails" at the nanometer scale.
  • AI-Driven Image Analysis: Developed a machine-learning model to quantify the morphology (length, thickness, curvature) of thousands of bacterial actin tails in an unbiased way.
  • Intravital Microscopy: Imaging live infections in mouse livers to see how bacteria spread in real-time.

Datasets

The study utilized several key data resources:

  • The Endogenous ISGylome: A previously mapped dataset of ISG15-modified proteins in the liver.
  • Listeria Actin Comet Tail Proteome: An existing dataset of proteins physically associated with the bacterial propulsion machinery.
  • Newly Generated Imaging Data: The authors have made their source code and annotated actin comet tail images available via Zenodo and GitHub.

Key Insights and Ideas

  • Steric Hindrance as Defense: Structural modeling suggests that when ISG15 attaches to the Arp3 subunit (at sites K18, K75, and K191), it physically blocks the complex from interacting with F-actin. It essentially acts like a "boot" on a car wheel, locking the Arp2/3 complex in an inactive state.
  • The "Bazooka" Effect: In states of hyper-ISGylation (where ISG15 isn't removed), Listeria division becomes messy. The bacteria fail to separate after dividing but keep their actin tails. This creates "multi-headed" bacterial clusters the authors termed "bazookas." These clusters have stabilized, powerful tails that allow them to push deeper into tissues than single bacteria.
  • Host Cytoskeleton Regulation: Beyond infection, ISGylation regulates the host's own "cortical actin" (the mesh under the cell membrane). Without ISG15, this mesh becomes diffuse, which explains why humans with ISG15 deficiencies suffer from chronic skin lesions and poor wound healing.

Key Results

  • Slowing the Spread: In wild-type cells, Listeria moves at 0.04 µm/s. In cells with enhanced ISGylation, this speed drops by more than half to 0.017 µm/s.
  • Pathogen Restriction: Vaccinia virus (VacV) spread was significantly restricted by ISGylation, as the virus cannot exploit the "bazooka" mechanism that Listeria uses.
  • Mortality: In mice with unchecked ISGylation (USP18 CA), Listeria infection was 100% lethal within 7 days, whereas all wild-type mice survived. This was due to the "bazooka" clusters spreading into hepatocytes (liver cells) that are normally protected.
  • Skin Integrity: ISG15-deficient neonatal mice showed a significantly thicker epidermis, correlating with the wound-healing defects seen in human patients.

Limitations and Future Work

The authors note that while mouse models are powerful, some human ISG15-related phenotypes (like brain calcification) are not perfectly recapitulated in mice. Furthermore, the study primarily used 2D cell cultures for motility assays; moving into 3D tissue models or organ-on-a-chip systems would better simulate the viscous environment of the human body.

Future research could explore whether tuning ISGylation could be a therapeutic strategy—not just for infections, but for slowing down cancer metastasis, which also relies heavily on Arp2/3-mediated cell movement.

Summary updated

Abstract

Summary The ubiquitin-like protein, ISG15, can act as a cytokine or can covalently modify host and pathogen-derived proteins. The consequences of ISG15 modification on substrate fate remain unknown. Here we reveal that ISGylation of the Arp2/3 complex slows actin filament formation and stabilizes Arp2/3 dependent structures including cortical actin and lamella. When properly controlled, this serves as an antibacterial and antiviral host defense strategy to directly restrict actin-mediated pathogen spread. However, Listeria monocytogenes takes advantage in models of dysregulated ISGylation, leading to increased mortality due to augmented spread. The underlying molecular mechanism responsible for the ISG15-dependent impact on actin-based motility is due to failed bacterial separation after division. This promotes spread by enabling the formation of multi-headed bacterial “bazookas” with stabilized comet tails that can disseminate deeper into tissues. A bacterial mutant that cannot recruit Arp2/3 or a non-ISGylatable mutant of Arp3 is sufficient to rescue slowed comet tail speed and restrict spread. Importantly, ISG15-deficient neonatal mice have aberrant epidermal epithelia characterized by keratinocytes with diffuse cortical actin, which could underlie observed defects in wound healing in human patients who lack ISG15. Ultimately, our discovery links host innate immune responses to cytoskeletal dynamics with therapeutic implications for viral infection and metastasis.
BibTeX
@misc{zhang2022isg,
  author = {Yifeng Zhang and Brittany M. Ripley and Wei Ouyang and Miranda Sturtz and Ellen M. Upton and Emma K. Luhmann and Madeleine Vessely and Rocío Coloma and Nathan Schwery and Scott M. Anthony and Adam Goeken and Thomas O. Moninger and John T. Harty and Aloysius J. Klingelhutz and Emma Lundberg and David K. Meyerholz and Balaji Manicassamy and Christopher S. Stipp and Susana Guerra and Lilliana Radoshevich},
  title = {{ISG15-modification of the Arp2/3 complex restricts pathogen spread}},
  year = {2022},
  doi = {10.1101/2022.12.27.522022},
  howpublished = {bioRxiv},
}
Figure